GlassScriptPhysician profile
John T Salter
NPI 1124031711
$19,218.72
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,407 · 2022: $65.02 · 2023: $250 · 2024: $27.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $16,503.04 | 2019-2020 | |
| Puma Biotechnology, INC. | $1,125.00 | 2019 | |
| Array Biopharma INC | $500.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $178.75 | 2019-2023 | Opdivo |
| Amgen INC. | $144.67 | 2019-2023 | Lumakras |
| Genentech USA, INC. | $141.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $127.39 | 2019 | |
| Janssen Biotech, INC. | $84.84 | 2019-2020 | |
| Pfizer INC. | $71.91 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $52.43 | 2019 | |
| Hologic Sales and Service, LLC | $33.82 | 2022 | |
| Celgene Corporation | $32.01 | 2019 | |
| Eisai INC. | $30.30 | 2019-2020 | |
| Tempus Ai, INC | $27.89 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.99 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $23.74 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.62 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.49 | 2019 | |
| Foundation Medicine, INC. | $15.42 | 2019 | |
| Aurobindo Pharma USA, INC. | $15.39 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $14.77 | 2019 | |
| Sandoz INC. | $14.41 | 2019 | |
| Glaxosmithkline, LLC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Salter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.